Risk of bias summary. by Ziyi Li (349831)

Subjects:

iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

Risk of cancers according to insomnia stratified by sex. by Kichul Yoon (3073767)

Subjects:

Risk of bias assessment. by Telford Y. Yeung (15361277)

“…In infants < 29 weeks’ gestation, STC significantly reduced the risk of BPD compared to controls (6 RCTs, N = 980; RR 0.63; 95% CI 0.47 to 0.85; NNTB = 8; CoE: moderate).…”

Kruskal Wallis test for statistically significant differences among PPE items by gender ^{^b'a', ^b'b'}. by Ștefan Andrei Neştian (14755581)

Ecological risk classification. by Jie Zhang (64655)

Subjects:

The relationship between longer TV watching time and risk of cognitive impairment. by Hattapark Dejakaisaya (22238613)

Results from the logistic regression of multimorbidity for adults aged 35 and above allowing significant interactions. by Xiang Xiao (44417)

Sex-differentiated risk signal volcano plot for finasteride. by Xiaoling Zhong (181270)

Impact of economic conditions, COVID-19 risk beliefs and anxiety. by Fabrice Etilé (4741332)

Subjects:

Plot showing the significant correlation between participant age and QOLI_TOTDIFF. by Roger D. Newman-Norlund (14053467)

Subjects:

Prevalence of the common NCD risk factors by region. by Ronald Kusolo (13200268)

Subjects:

Prevalence of the common NCD risk factors by Urbanicity. by Ronald Kusolo (13200268)

Subjects:

Risk factors for HBsAg positivity among pregnant women. by Fatima K. Khalid (13296667)

Subjects:

Significant associations (q<0.1) between maternal trimester-specific phthalates and metabolites among 110 boys. by Jaclyn M. Goodrich (6855335)

Significant associations (q<0.1) between maternal trimester-specific phthalates and metabolites among 234 children. by Jaclyn M. Goodrich (6855335)

Reviewer’ judgments about each risk of bias item for each included study. by Xiaodong Jia (783460)

Subjects:

Risk Classification Diagram of Hot Surface. by Lei Bai (631944)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”